The European Medicines Agency (EMA) and Australia’s Therapeutic Goods Administration (TGA) have announced that they are to share the full assessment reports related to marketing authorisations (MA) for orphan drugs.
Read more at: http://www.pharmatimes.com/Article/14-04-07/EU_and_Australia_link_up_on_orphan_drugs.aspx#ixzz2yMSKhCyG
Filed under: Uncategorized
